H.R. 6664
118th Congress
House
Innovation in Pediatric Drugs Act of 2023
Official title: To encourage innovation in the development of pediatric drugs, and for other purposes.
Health
Child healthCongressional oversightDrug safety, medical device, and laboratory regulationGovernment information and archives
More subjectsShow fewer subjects
Government studies and investigationsHealth programs administration and fundingMedical researchPrescription drugsResearch administration and funding
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 8, 2023
Referred to the Subcommittee on Health.
Dec 7, 2023
Referred to the House Committee on Energy and Commerce.
Dec 7, 2023
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Lobbying activity
2
Bodies those filers lobbied
Cite this page
U.S. Congress. (2026). H.R. 6664: Innovation in Pediatric Drugs Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-6664/
"H.R. 6664: Innovation in Pediatric Drugs Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-6664/.
H.R. 6664, 118th Cong. (2026), https://openamerica.io/bill/118-HR-6664/.
[H.R. 6664: Innovation in Pediatric Drugs Act of 2023](https://openamerica.io/bill/118-HR-6664/)